For the Inventor, By the Inventor

Enter assignee name

Mercian Corporation

USPTO Granted Patents = 40

EPO Patents = 6

Trademarks = 3

Forward Citations = 147

Loading Chart...

Loading Chart...

101 inventors (with patents filed for the assignee):

Takeo Yoshioka (21 out of 41 patents)

Takashi Nakashima (13 out of 22 patents)

Kunio Isshiki (10 out of 16 patents)

4. Toshio Tsuchida (9 out of 15 patents)

5. Kazuyuki Dobashi (7 out of 9 patents)

6. Rokuro Okamoto (6 out of 20 patents)

7. Mitsuo Nagai (5 out of 28 patents)

8. Tomohiro Sameshima (5 out of 7 patents)

9. Takao Narita (5 out of 5 patents)

10. Hiroshi Tone (5 out of 13 patents)

11. Jun Niijima (4 out of 24 patents)

12. Masashi Yoshida (4 out of 9 patents)

13. Yoshihiko Kotake (4 out of 26 patents)

14. Susumu Takeda (4 out of 6 patents)

15. Naoto Kawamura (4 out of 7 patents)

Core Competencies:

Macrolide Compounds

Physiologically Active Substances

Heterocyclic Macrolide

Osteoclast Differentiation Inhibitors

Isocoumarin Derivatives

Dihydroxycholesterol

Optically Active Compounds

Biological Production Processes

Antitumor Agents

Cyclodextrin Production

Hydroxyvitamin D Compounds

4-Hydroxypyridine Derivatives

40 patents: Sort by Forward Citations

1. 7932083 - DNA participating in hydroxylation of macrolide compound (2011-04-26),

2. 7893068 - Physiologically active substances (2011-02-22),

3. 7790887 - Macrolide compound in solid form, process for preparation thereof, and pharmaceutical composition containing the same (2010-09-07),

4. 7745198 - Method of producing macrolide compound (2010-06-29),

5. 7655442 - Method for stabilizing macrolide compounds (2010-02-02),

6. 7619100 - Physiologically active substances (2009-11-17),

7. 7576204 - Heterocyclic macrolide pharmaceutical agent, a method of producing the same and use of the same (2009-08-18),

8. 7256178 - Physiologically active substances (2007-08-14),

9. 7247729 - Method for producing pipecolamide derivative (2007-07-24),

10. 7235388 - Isolated nucleic acid encoding L-lysine: 2-oxoglutaric acid 6-aminotransferase (2007-06-26),

11. 7115412 - Process for the preparation of optically active 7-substituted-3-(2-aminopropyl)indole derivatives and intermediates therefor (2006-10-03),

12. 7060821 - Osteoclast differentiation inhibitors (2006-06-13),

13. 7026352 - Physiologically active substances (2006-04-11),

14. 7022502 - Process for the biological production of L-pipecolic acid (2006-04-04),

15. 6900340 - Preparation of isocoumarin derivatives and intermediates for the synthesis thereof (2005-05-31),

Mercian Corporation is a multinational conglomerate specializing in various industries such as technology, healthcare, and energy. With a rich history spanning over five decades, Mercian Corporation has grown to become a global leader in innovation, research, and development. Our mission is to provide cutting-edge solutions that enhance people's lives and drive sustainable growth. Visit our website to learn more about our diverse range of products and services offered across the globe.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

40 Patents

#817 in Tokyo

#1,934 in Japan

#16,570 in the World

Mercian Corporation

Forward Citations = 147

101 inventors:

Takeo Yoshioka (21 out of 41 patents)

Takashi Nakashima (13 out of 22 patents)

Kunio Isshiki (10 out of 16 patents)

4. Toshio Tsuchida (9 out of 15 patents)

5. Kazuyuki Dobashi (7 out of 9 patents)

Please report any incorrect information to support@idiyas.com

Loading…